NCT05385432View on ClinicalTrials.gov

Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

244

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2030

Conditions

Renal Transplant RejectionInduction Therapy

Interventions

DRUG

Rabbit Anti thymocyte globulin (rATG)

The infusion of rTAG (Thymoglobulin® (1.5mg/kg/day, maximum daily dose: 100 mg)) starts just after the randomization pre-operatively on a functional arteriovenous fistula or a high-flow venous catheter during 3 to 7 days until efficient tacrolimus level is obtained.

DRUG

Basiliximab

Simulect® IV 40mg D0 and D4

All Listed Sponsors

lead

University Hospital, Tours

OTHER

NCT05385432 - Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies | Biotech Hunter | Biotech Hunter